Noninvasive Diagnosis of NAFLD and NASH
The aim of this review is to outline emerging biomarkers that can serve as early diagnostic tools to identify patients with nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) and, among them, the subgroup of best candidates for clinical trials on emerging compounds. Reg...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
MDPI AG
2020-04-01
|
| Schriftenreihe: | Cells |
| Schlagworte: | |
| Online-Zugang: | https://www.mdpi.com/2073-4409/9/4/1005 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|